Clinigen is unique in offering access to medicines at all stages of the pharmaceutical product life cycle from clinical trials and managing early access programmes through to mature products towards the end of their life cycle.

 

  • Unique combination of Businesses -¬†extending across pharmaceutical product life cycle with clear synergies

  • Market-leading positions - #1 in CTS, Managed Access and Global Access

  • Significant long-term growth potential - both organic and acquisitional growth opportunity

  • Highly cash generative - with strong cost control

  • Unparalleled knowledge and expertise - in supply of unlicensed medicines

  • Global capability - supplying into 113 countries

  • Trusted ethical supplier - deep relationships with physicians and big Pharma

  • Experienced management team - delivering track record of growth